Lung Bioavailability With Continuous or Discontinuous Nebulization

Not Applicable

Completed

• Conditions: Healthy Subjects
• Interventions: Device: AKITA

• Registration Number: NCT01913184
• Lead Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Brief Summary

To compare the continuous and sicontinuous delivery of drug with AKITA.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04
• Primary Completion: 2012-05
• Study Completion: 2012-06
• Status Verified: 2013-07
• Study First Submitted: 2013-07-29
• Study First Submitted QC: 2013-07-30
• Last Update Submitted: 2013-07-30
• Study First Posted: 2013-07-31
• Last Update Posted: 2013-07-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 6

Inclusion Criteria

• no lung disease
• no allergy

Exclusion Criteria

• smoker

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Continuous nebulization	AKITA	Continuous nebulization with AKITA
Discontinuous nebulization	AKITA	Discontinuous nebulization with AKITA

Primary Outcome Measures

Name	Time	Method
Lung bioavailability by urinary monitoring	24h after the nebulization

Secondary Outcome Measures

Name	Time	Method
Duration of the nebulization	After the nebulization

Trial Locations

Locations (1)

Cliniques universitaires Saint-Luc; 🇧🇪 Brussels, Belgium